- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
ASTRO's New Guidelines on Post-operative Radiation Therapy for Endometrial Cancer
The American Society for Radiation Oncology (ASTRO) has issued a new guideline, The Role of Postoperative Radiation Therapy for Endometrial Cancer: An ASTRO Evidence-Based Guideline, that details the use of adjuvant radiation therapy in the treatment of endometrial cancer. The guideline's executive summary is published in the May-June 2014 issue of Practical Radiation Oncology (PRO), the official clinical practice journal of ASTRO. The full-length guideline is available as an open-access article online.
The American Society for Radiation Oncology (ASTRO) has
issued a new guideline, “The Role of Postoperative Radiation Therapy for Endometrial Cancer: An
ASTRO Evidence-Based Guideline,” that details the use of adjuvant radiation therapy in the
treatment of endometrial cancer. The guideline’s executive summary is published in the May-June
2014 issue of Practical Radiation Oncology (PRO), the official clinical practice journal of ASTRO.
The
full-length guideline is available as an open-access article online at www.practicalradonc.org.
ASTRO’s Guidelines Panel of 17 leading gynecologic specialists compiled and reviewed
extensive data from 330 studies from MEDLINE, EMBASE and the Specialized Register of the
Cochrane Gynaecological Cancer Review Group published from 1980 to 2011. The data population
selected for the guideline was defined as women of all races, age 18 or older, with stage I-IV
endometrial cancer of any histologic type or grade. The studies included patients who underwent a
hysterectomy followed by no adjuvant therapy, or pelvic and/or vaginal brachytherapy with or
without systemic chemotherapy. The panel identified five key questions about the role of adjuvant
radiation therapy and developed a series of recommendations to address each question.
Source: ASTRO
Read the press release here:
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care
November 13th 2024Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.
Read More
